nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—DRD2—Gilles de la Tourette syndrome	0.456	0.564	CbGaD
Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.353	0.436	CbGaD
Thioridazine—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00591	0.117	CbGeAlD
Thioridazine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00369	0.0727	CbGeAlD
Thioridazine—HTR6—nervous system—Gilles de la Tourette syndrome	0.00161	0.0317	CbGeAlD
Thioridazine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00155	0.0306	CbGeAlD
Thioridazine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00146	0.0287	CbGeAlD
Thioridazine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00128	0.0253	CbGeAlD
Thioridazine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00124	0.0244	CbGeAlD
Thioridazine—HTR6—brain—Gilles de la Tourette syndrome	0.00123	0.0243	CbGeAlD
Thioridazine—DRD1—nervous system—Gilles de la Tourette syndrome	0.0012	0.0236	CbGeAlD
Thioridazine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.00115	0.0227	CbGeAlD
Thioridazine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00113	0.0223	CbGeAlD
Thioridazine—ADRA1B—brain—Gilles de la Tourette syndrome	0.000981	0.0194	CbGeAlD
Thioridazine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000965	0.019	CbGeAlD
Thioridazine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000952	0.0188	CbGeAlD
Thioridazine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00093	0.0183	CbGeAlD
Thioridazine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000929	0.0183	CbGeAlD
Thioridazine—DRD1—brain—Gilles de la Tourette syndrome	0.000915	0.0181	CbGeAlD
Thioridazine—HTR7—midbrain—Gilles de la Tourette syndrome	0.00091	0.018	CbGeAlD
Thioridazine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000895	0.0177	CbGeAlD
Thioridazine—DRD2—midbrain—Gilles de la Tourette syndrome	0.00086	0.017	CbGeAlD
Thioridazine—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000847	0.0167	CbGeAlD
Thioridazine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000782	0.0154	CbGeAlD
Thioridazine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000753	0.0149	CbGeAlD
Thioridazine—HTR7—nervous system—Gilles de la Tourette syndrome	0.000748	0.0148	CbGeAlD
Thioridazine—CHRM2—brain—Gilles de la Tourette syndrome	0.000737	0.0145	CbGeAlD
Thioridazine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000721	0.0142	CbGeAlD
Thioridazine—HTR7—central nervous system—Gilles de la Tourette syndrome	0.00072	0.0142	CbGeAlD
Thioridazine—HTR2C—brain—Gilles de la Tourette syndrome	0.000711	0.014	CbGeAlD
Thioridazine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000707	0.014	CbGeAlD
Thioridazine—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000697	0.0137	CbGeAlD
Thioridazine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000694	0.0137	CbGeAlD
Thioridazine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000681	0.0134	CbGeAlD
Thioridazine—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.000671	0.0132	CbGeAlD
Thioridazine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000667	0.0132	CbGeAlD
Thioridazine—HTR1A—brain—Gilles de la Tourette syndrome	0.000598	0.0118	CbGeAlD
Thioridazine—HTR7—brain—Gilles de la Tourette syndrome	0.000572	0.0113	CbGeAlD
Thioridazine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000567	0.0112	CbGeAlD
Thioridazine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000558	0.011	CbGeAlD
Thioridazine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000551	0.0109	CbGeAlD
Thioridazine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000548	0.0108	CbGeAlD
Thioridazine—DRD2—brain—Gilles de la Tourette syndrome	0.00054	0.0107	CbGeAlD
Thioridazine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000538	0.0106	CbGeAlD
Thioridazine—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.000537	0.0106	CbGeAlD
Thioridazine—KCNH2—brain—Gilles de la Tourette syndrome	0.000532	0.0105	CbGeAlD
Thioridazine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000528	0.0104	CbGeAlD
Thioridazine—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.000517	0.0102	CbGeAlD
Thioridazine—CYP2C8—brain—Gilles de la Tourette syndrome	0.000487	0.00961	CbGeAlD
Thioridazine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000466	0.0092	CbGeAlD
Thioridazine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000449	0.00886	CbGeAlD
Thioridazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000447	0.0493	CrCbGaD
Thioridazine—HRH1—brain—Gilles de la Tourette syndrome	0.000427	0.00842	CbGeAlD
Thioridazine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000425	0.00838	CbGeAlD
Thioridazine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000419	0.00827	CbGeAlD
Thioridazine—CYP2E1—brain—Gilles de la Tourette syndrome	0.00041	0.00809	CbGeAlD
Thioridazine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000409	0.00807	CbGeAlD
Thioridazine—HTR2A—brain—Gilles de la Tourette syndrome	0.000356	0.00703	CbGeAlD
Thioridazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.000348	0.0384	CrCbGaD
Thioridazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.00034	0.0375	CrCbGaD
Thioridazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000337	0.0372	CrCbGaD
Thioridazine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000325	0.00641	CbGeAlD
Thioridazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000305	0.0337	CrCbGaD
Thioridazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000305	0.0336	CrCbGaD
Thioridazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000291	0.0321	CrCbGaD
Thioridazine—Zuclopenthixol—DRD2—Gilles de la Tourette syndrome	0.000283	0.0312	CrCbGaD
Thioridazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.000274	0.0302	CrCbGaD
Thioridazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000254	0.028	CrCbGaD
Thioridazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000252	0.0278	CrCbGaD
Thioridazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000251	0.0276	CrCbGaD
Thioridazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000248	0.0273	CrCbGaD
Thioridazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000244	0.0269	CrCbGaD
Thioridazine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.000244	0.0269	CrCbGaD
Thioridazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.000241	0.0266	CrCbGaD
Thioridazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000233	0.0257	CrCbGaD
Thioridazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000222	0.0244	CrCbGaD
Thioridazine—Zuclopenthixol—HTR2A—Gilles de la Tourette syndrome	0.000219	0.0241	CrCbGaD
Thioridazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000211	0.0233	CrCbGaD
Thioridazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000203	0.0224	CrCbGaD
Thioridazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000196	0.0216	CrCbGaD
Thioridazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000192	0.0211	CrCbGaD
Thioridazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000191	0.0211	CrCbGaD
Thioridazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000188	0.0208	CrCbGaD
Thioridazine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.000188	0.0208	CrCbGaD
Thioridazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.000186	0.0205	CrCbGaD
Thioridazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000173	0.0191	CrCbGaD
Thioridazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000171	0.0188	CrCbGaD
Thioridazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000168	0.0186	CrCbGaD
Thioridazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000167	0.0184	CrCbGaD
Thioridazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000163	0.018	CrCbGaD
Thioridazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.000157	0.0173	CrCbGaD
Thioridazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.00015	0.0166	CrCbGaD
Thioridazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000149	0.0164	CrCbGaD
Thioridazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000134	0.0148	CrCbGaD
Thioridazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000132	0.0146	CrCbGaD
Thioridazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000132	0.0146	CrCbGaD
Thioridazine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00013	0.000992	CbGpPWpGaD
Thioridazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.00013	0.0144	CrCbGaD
Thioridazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00013	0.000988	CbGpPWpGaD
Thioridazine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00013	0.000986	CbGpPWpGaD
Thioridazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00013	0.000985	CbGpPWpGaD
Thioridazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000129	0.0142	CrCbGaD
Thioridazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000129	0.000979	CbGpPWpGaD
Thioridazine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000129	0.000978	CbGpPWpGaD
Thioridazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000127	0.000964	CbGpPWpGaD
Thioridazine—HTR6—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000126	0.000956	CbGpPWpGaD
Thioridazine—HTR7—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000126	0.000955	CbGpPWpGaD
Thioridazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000125	0.00095	CbGpPWpGaD
Thioridazine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000124	0.000943	CbGpPWpGaD
Thioridazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000123	0.000937	CbGpPWpGaD
Thioridazine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000123	0.000936	CbGpPWpGaD
Thioridazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000123	0.000935	CbGpPWpGaD
Thioridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000122	0.000929	CbGpPWpGaD
Thioridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000122	0.000925	CbGpPWpGaD
Thioridazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000121	0.00092	CbGpPWpGaD
Thioridazine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000121	0.000919	CbGpPWpGaD
Thioridazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000121	0.000918	CbGpPWpGaD
Thioridazine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00012	0.000915	CbGpPWpGaD
Thioridazine—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00012	0.00091	CbGpPWpGaD
Thioridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000119	0.000902	CbGpPWpGaD
Thioridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000117	0.000888	CbGpPWpGaD
Thioridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000116	0.000886	CbGpPWpGaD
Thioridazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000116	0.000885	CbGpPWpGaD
Thioridazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000116	0.000884	CbGpPWpGaD
Thioridazine—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000116	0.000884	CbGpPWpGaD
Thioridazine—Promazine—HTR2A—Gilles de la Tourette syndrome	0.000116	0.0128	CrCbGaD
Thioridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000116	0.000879	CbGpPWpGaD
Thioridazine—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000116	0.000878	CbGpPWpGaD
Thioridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000115	0.000876	CbGpPWpGaD
Thioridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000115	0.000875	CbGpPWpGaD
Thioridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000115	0.000872	CbGpPWpGaD
Thioridazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000114	0.000869	CbGpPWpGaD
Thioridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000113	0.000862	CbGpPWpGaD
Thioridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000113	0.00086	CbGpPWpGaD
Thioridazine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000112	0.000853	CbGpPWpGaD
Thioridazine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000111	0.000847	CbGpPWpGaD
Thioridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000111	0.000846	CbGpPWpGaD
Thioridazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000111	0.000844	CbGpPWpGaD
Thioridazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00011	0.000837	CbGpPWpGaD
Thioridazine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000109	0.000831	CbGpPWpGaD
Thioridazine—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000108	0.000823	CbGpPWpGaD
Thioridazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000106	0.000808	CbGpPWpGaD
Thioridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000106	0.000803	CbGpPWpGaD
Thioridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000105	0.000801	CbGpPWpGaD
Thioridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000104	0.000788	CbGpPWpGaD
Thioridazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000103	0.000786	CbGpPWpGaD
Thioridazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000103	0.000784	CbGpPWpGaD
Thioridazine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000103	0.000783	CbGpPWpGaD
Thioridazine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000102	0.000779	CbGpPWpGaD
Thioridazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	0.000102	0.0113	CrCbGaD
Thioridazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.99e-05	0.00076	CbGpPWpGaD
Thioridazine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.99e-05	0.00076	CbGpPWpGaD
Thioridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.96e-05	0.000758	CbGpPWpGaD
Thioridazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.95e-05	0.000757	CbGpPWpGaD
Thioridazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.94e-05	0.000756	CbGpPWpGaD
Thioridazine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.94e-05	0.000756	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.8e-05	0.000745	CbGpPWpGaD
Thioridazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.78e-05	0.000744	CbGpPWpGaD
Thioridazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.61e-05	0.000731	CbGpPWpGaD
Thioridazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.51e-05	0.000724	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.51e-05	0.000724	CbGpPWpGaD
Thioridazine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.31e-05	0.000708	CbGpPWpGaD
Thioridazine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.26e-05	0.000704	CbGpPWpGaD
Thioridazine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.04e-05	0.000687	CbGpPWpGaD
Thioridazine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.89e-05	0.000676	CbGpPWpGaD
Thioridazine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.87e-05	0.000675	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.86e-05	0.000674	CbGpPWpGaD
Thioridazine—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.81e-05	0.00067	CbGpPWpGaD
Thioridazine—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.8e-05	0.000669	CbGpPWpGaD
Thioridazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.77e-05	0.000667	CbGpPWpGaD
Thioridazine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.77e-05	0.000667	CbGpPWpGaD
Thioridazine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.73e-05	0.000664	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.71e-05	0.000662	CbGpPWpGaD
Thioridazine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.63e-05	0.000656	CbGpPWpGaD
Thioridazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.61e-05	0.000655	CbGpPWpGaD
Thioridazine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.61e-05	0.000655	CbGpPWpGaD
Thioridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.56e-05	0.000651	CbGpPWpGaD
Thioridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.52e-05	0.000648	CbGpPWpGaD
Thioridazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.47e-05	0.000644	CbGpPWpGaD
Thioridazine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.47e-05	0.000644	CbGpPWpGaD
Thioridazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.45e-05	0.000643	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.45e-05	0.000643	CbGpPWpGaD
Thioridazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.15e-05	0.00062	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.09e-05	0.000615	CbGpPWpGaD
Thioridazine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.04e-05	0.000611	CbGpPWpGaD
Thioridazine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.02e-05	0.00061	CbGpPWpGaD
Thioridazine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.89e-05	0.0006	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.87e-05	0.000599	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.86e-05	0.000597	CbGpPWpGaD
Thioridazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.85e-05	0.000597	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.85e-05	0.000597	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.85e-05	0.000597	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	7.76e-05	0.00059	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.63e-05	0.00058	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.62e-05	0.000579	CbGpPWpGaD
Thioridazine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.58e-05	0.000576	CbGpPWpGaD
Thioridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.52e-05	0.000572	CbGpPWpGaD
Thioridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.38e-05	0.000561	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.31e-05	0.000556	CbGpPWpGaD
Thioridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.26e-05	0.000552	CbGpPWpGaD
Thioridazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.24e-05	0.000551	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.13e-05	0.000543	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.13e-05	0.000542	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	7.12e-05	0.000542	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.1e-05	0.00054	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.1e-05	0.00054	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.93e-05	0.000527	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.92e-05	0.000526	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.76e-05	0.000514	CbGpPWpGaD
Thioridazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.73e-05	0.000512	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.57e-05	0.000499	CbGpPWpGaD
Thioridazine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.52e-05	0.000496	CbGpPWpGaD
Thioridazine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.48e-05	0.000493	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.45e-05	0.000491	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.44e-05	0.00049	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.21e-05	0.000472	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	6.16e-05	0.000468	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.14e-05	0.000467	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.12e-05	0.000465	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.96e-05	0.000453	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.82e-05	0.000442	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.79e-05	0.00044	CbGpPWpGaD
Thioridazine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.72e-05	0.000435	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.65e-05	0.000429	CbGpPWpGaD
Thioridazine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.62e-05	0.000427	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.62e-05	0.000427	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.55e-05	0.000422	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.54e-05	0.000421	CbGpPWpGaD
Thioridazine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.53e-05	0.00042	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.51e-05	0.000419	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	5.49e-05	0.000418	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.38e-05	0.000409	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.28e-05	0.000402	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.26e-05	0.0004	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.25e-05	0.0004	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.23e-05	0.000398	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.13e-05	0.00039	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.12e-05	0.00039	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.11e-05	0.000388	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.1e-05	0.000388	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	5.05e-05	0.000384	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.03e-05	0.000382	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.02e-05	0.000382	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.01e-05	0.000381	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	5.01e-05	0.000381	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.01e-05	0.000381	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.98e-05	0.000378	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.97e-05	0.000378	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.96e-05	0.000377	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.93e-05	0.000375	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.92e-05	0.000374	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.88e-05	0.000371	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.88e-05	0.000371	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.87e-05	0.00037	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.79e-05	0.000364	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.78e-05	0.000363	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.78e-05	0.000363	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.75e-05	0.000361	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.64e-05	0.000353	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.57e-05	0.000348	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.56e-05	0.000347	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.55e-05	0.000346	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.55e-05	0.000346	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.54e-05	0.000346	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.53e-05	0.000345	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.52e-05	0.000344	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.51e-05	0.000343	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.5e-05	0.000342	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.48e-05	0.000341	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.47e-05	0.00034	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.46e-05	0.000339	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.45e-05	0.000338	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.44e-05	0.000337	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.43e-05	0.000337	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.42e-05	0.000336	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.35e-05	0.000331	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.34e-05	0.00033	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.28e-05	0.000326	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	4.28e-05	0.000326	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.21e-05	0.000321	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.21e-05	0.00032	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.15e-05	0.000316	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.13e-05	0.000314	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.13e-05	0.000314	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.12e-05	0.000313	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.09e-05	0.000311	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.09e-05	0.000311	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.05e-05	0.000308	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.04e-05	0.000307	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.03e-05	0.000306	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.89e-05	0.000296	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.81e-05	0.00029	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.81e-05	0.00029	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.75e-05	0.000285	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.68e-05	0.00028	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.66e-05	0.000279	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.63e-05	0.000276	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.52e-05	0.000268	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.51e-05	0.000267	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.35e-05	0.000254	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.33e-05	0.000253	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.28e-05	0.00025	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.23e-05	0.000246	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.19e-05	0.000242	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.18e-05	0.000241	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.12e-05	0.000238	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.12e-05	0.000237	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.12e-05	0.000237	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.1e-05	0.000236	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.03e-05	0.00023	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.01e-05	0.000229	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.97e-05	0.000226	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.94e-05	0.000223	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.9e-05	0.00022	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.88e-05	0.000219	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.88e-05	0.000219	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.84e-05	0.000216	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.83e-05	0.000215	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.82e-05	0.000215	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.81e-05	0.000213	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.74e-05	0.000208	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.7e-05	0.000205	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.69e-05	0.000205	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.69e-05	0.000204	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.67e-05	0.000203	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.67e-05	0.000203	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.66e-05	0.000202	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.65e-05	0.000201	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.64e-05	0.000201	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.63e-05	0.0002	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.62e-05	0.000199	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.61e-05	0.000199	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.57e-05	0.000195	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.56e-05	0.000195	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000186	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.44e-05	0.000185	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.43e-05	0.000185	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.39e-05	0.000182	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.39e-05	0.000182	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000181	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.3e-05	0.000175	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.000169	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.98e-05	0.00015	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.00015	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.88e-05	0.000143	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.73e-05	0.000132	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.7e-05	0.00013	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.68e-05	0.000127	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.67e-05	0.000127	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.000118	CbGpPWpGaD
